A pharmaceutically acceptable salt of a compound comprising viral polymerase inhibitor for use in medicines.
PK201100239A0Undetermined Publication Date: 2011-04-19BOEHRINGER INGELHEIM CANADA LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201100239
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2011-04-05
- Publication Date
- 2011-04-19
Abstract
The present invention provides a pharmaceutically acceptable salt of a compound, or an isomer, enantiomer, diastereoisomer, or tautomer thereof represented by formula (IIc): wherein substituents are define in claim 1. The invention further provides a pharmaceutical composition comprising a salt of a compound for use in the treatment of HCV infection.
Need to check novelty before this filing date? Find Prior Art